Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal barrier and immune system constitute a complex physiological entity essential for maintaining homeostasis by balancing nutrient absorption with protection against luminal pathogens. The physical barrier is composed of a specialized epithelial layer maintained by tight junction proteins, such as claudins and occludin, and a protective mucus layer (Vancamelbeke & Vermeire, 2017). Beneath this, the gut-associated lymphoid tissue (GALT) coordinates immune tolerance and active defense through a network of T cells, B cells, and dendritic cells (Okumura & Takeda, 2017). Dysregulation of this environment, characterized by increased permeability and chronic inflammation, is a central driver in the pathogenesis of inflammatory bowel disease (IBD), celiac disease, and various systemic inflammatory conditions (Turner, 2009). While not a single molecular target, this system is modulated by drugs that target specific components like integrins or cytokines to restore barrier function and immune balance (Chelakkot et al., Experimental & molecular medicine, 2018).
Therapeutic strategies involve modulating leukocyte trafficking to the gut mucosa (e.g., via α4β7 integrin antagonism), neutralizing pro-inflammatory cytokines (e.g., TNF-alpha, IL-12/23), and enhancing the structural integrity of epithelial tight junctions to restore barrier function (Turner, J. R., Nature reviews. Immunology, 2009; Vancamelbeke & Vermeire, Therapeutic advances in gastroenterology, 2017).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal barrier and immune system.